1006876-28-3 Usage
General Description
N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)picolinaMide is a chemical compound with the formula C16H24BN2O3. It is a boronic ester derivative of picolinamide, and it is commonly used in organic synthesis as a building block for various pharmaceutical and agrochemical products. N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)picolinaMide is known for its ability to form stable complexes with diols and polyols, making it a valuable tool in the development of new drugs and materials. It has also been studied for its potential use in the treatment of diabetes, cancer, and other diseases. Additionally, N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)picolinaMide is considered to be relatively safe and non-toxic, making it suitable for use in lab research and chemical manufacturing.
Check Digit Verification of cas no
The CAS Registry Mumber 1006876-28-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,8,7 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1006876-28:
(9*1)+(8*0)+(7*0)+(6*6)+(5*8)+(4*7)+(3*6)+(2*2)+(1*8)=143
143 % 10 = 3
So 1006876-28-3 is a valid CAS Registry Number.
1006876-28-3Relevant articles and documents
HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
-
Page/Page column 211; 213, (2019/08/12)
This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.
AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS
-
Page/Page column 18, (2009/05/28)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful for the treatment of diabetes and as peripheral regulators of satiety, e.g. for the treatment of obesity and metabolic syndrome.
